48.53
price down icon0.21%   -0.10
after-market Dopo l'orario di chiusura: 48.53
loading

Anaptysbio Inc Borsa (ANAB) Ultime notizie

pulisher
Oct 01, 2026

Director Hollings C. Renton plans to sell 5,000 AnaptysBio (ANAB) shares valued at about $249K. - Stock Titan

Oct 01, 2026
pulisher
Sep 30, 2026

ANAB Maintained by JP Morgan -- Price Target Lowered to $60.00 - GuruFocus

Sep 30, 2026
pulisher
Sep 30, 2026

JPMorgan Chase & Co. Cuts AnaptysBio (NASDAQ:ANAB) Price Target to $60.00 - MarketBeat

Sep 30, 2026
pulisher
Sep 26, 2026

Is AnaptysBio (ANAB) Cheap On Its Royalty Story Despite Tax Driven Earnings? - Simply Wall Street

Sep 26, 2026
pulisher
Sep 26, 2026

AnaptysBio (ANAB) Is Down 7.6% After Tax-Driven Earnings Surge Masks Underlying Cash Performance - Yahoo Finance

Sep 26, 2026
pulisher
Sep 26, 2026

AnaptysBio (NASDAQ:ANAB) Stock Bumped Up to Buy by Wall Street Zen - MarketBeat

Sep 26, 2026
pulisher
Sep 25, 2026

AnaptysBio (ANAB) Reports a Tax-Driven Profit. When Will Royalties Fund Shareholder Returns? - Insider Monkey

Sep 25, 2026
pulisher
Sep 25, 2026

How Return To Profit Will Impact AnaptysBio (ANAB) Investors - simplywall.st

Sep 25, 2026
pulisher
Sep 24, 2026

ANAB Reiterated by HC Wainwright & Co. -- Price Target Maintained at $95 - GuruFocus

Sep 24, 2026
pulisher
Sep 24, 2026

Q3 Earnings Estimate for AnaptysBio Issued By HC Wainwright - MarketBeat

Sep 24, 2026
pulisher
Sep 23, 2026

ANAB Maintained by Leerink Partners -- Price Target Lowered to $81 - GuruFocus

Sep 23, 2026
pulisher
Sep 23, 2026

Leerink Partners Maintains AnaptysBio(ANAB.US) With Buy Rating, Announces Target Price $81 - Moomoo

Sep 23, 2026
pulisher
Sep 23, 2026

Leerink Partners Issues Pessimistic Forecast for AnaptysBio (NASDAQ:ANAB) Stock Price - MarketBeat

Sep 23, 2026
pulisher
Sep 23, 2026

Leerink Partners maintains Outperform rating on AnaptysBio, $81 price target - TradingView

Sep 23, 2026
pulisher
Sep 23, 2026

AnaptysBio (ANAB) Flags Positive AZUR 1 Data With Approval And Legal Timelines - Simply Wall Street

Sep 23, 2026
pulisher
Sep 23, 2026

Bank of America Corp DE Makes New $28.20 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 23, 2026
pulisher
Sep 23, 2026

AnaptysBio, Inc. (NASDAQ:ANAB) Given Average Recommendation of "Moderate Buy" by Analysts - MarketBeat

Sep 23, 2026
pulisher
Sep 22, 2026

AnaptysBio earnings analysis: questions answered and next catalysts By Investing.com - Investing.com Nigeria

Sep 22, 2026
pulisher
Sep 22, 2026

AnaptysBio earnings analysis: questions answered and next catalysts - Investing.com

Sep 22, 2026
pulisher
Sep 22, 2026

AnaptysBio (NASDAQ:ANAB) Shares Down 6.2%What's Next? - MarketBeat

Sep 22, 2026
pulisher
Sep 22, 2026

AnaptysBio, Inc. (0HFQ.L) latest press releases and corporate news - Yahoo Finance UK

Sep 22, 2026
pulisher
Sep 22, 2026

AnaptysBio, Inc. (ANAB) Stock Price, News, Quote & History - Yahoo! Finance Canada

Sep 22, 2026
pulisher
Sep 22, 2026

AnaptysBio, Inc. (ANAB) Tops Q2 EPS by 524c - StreetInsider

Sep 22, 2026
pulisher
Sep 22, 2026

Why is AnaptysBio stock rising afterhours today? - Investing.com

Sep 22, 2026
pulisher
Sep 22, 2026

Why is AnaptysBio stock rising afterhours today? By Investing.com - Investing.com India

Sep 22, 2026
pulisher
Sep 21, 2026

AnaptysBio Net Income Jumps to $177.3 Million on $181.5 Million Tax Benefit - Minichart

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio, Inc. (ANAB) Reports Q2 Loss, Tops Revenue Estimates - Yahoo Finance

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio Inc (ANAB) Q2 Revenue Beats Estimates; Price-to-Sales Ratio Signals High Growth Expectations - GuruFocus

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio Swings to Q2 Profit as Revenue Rises; Shares Gain After Hours - marketscreener.com

Sep 21, 2026
pulisher
Sep 21, 2026

Anaptys Q2FY26 Results: Net profit jumps on $181.5m tax benefit - scanx.trade

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio : Annual Transition Report (Form 10-KT) - marketscreener.com

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio Q2 collaboration revenue rises on higher Jemperli royalties - TradingView

Sep 21, 2026
pulisher
Sep 21, 2026

Spin-off leaves AnaptysBio (ANAB) a lean royalty firm - Stock Titan

Sep 21, 2026
pulisher
Sep 21, 2026

AnaptysBio, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2026 - marketscreener.com

Sep 21, 2026
pulisher
Sep 18, 2026

Anaptysbio Stock Price Forecast. Should You Buy ANAB? - StockInvest.us

Sep 18, 2026
pulisher
Sep 18, 2026

AnaptysBio, Inc. (ANAB) Stock Analysis: Exploring A Potential 62.78% Upside - DirectorsTalk Interviews

Sep 18, 2026
pulisher
Sep 17, 2026

AnaptysBio (ANAB) director adds shares as RSUs vest - Stock Titan

Sep 17, 2026
pulisher
Sep 14, 2026

Alphyn Capital on Its Special-Situation Investment: AnaptysBio (ANAB) - Yahoo Finance

Sep 14, 2026
pulisher
Sep 10, 2026

AnaptysBio earnings on deck: Jemperli lawsuit takes center stage By Investing.com - Investing.com Nigeria

Sep 10, 2026
pulisher
Sep 10, 2026

AnaptysBio earnings on deck: Jemperli lawsuit takes center stage - investing.com

Sep 10, 2026
pulisher
Sep 10, 2026

ANAB Q2'26 Earnings: EPS estimate is (0.47) USD - TradingView

Sep 10, 2026
pulisher
Sep 09, 2026

Squarepoint Ops LLC Has $21.90 Million Position in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 09, 2026
pulisher
Sep 09, 2026

AnaptysBio, Inc. $ANAB Shares Purchased by Hsbc Holdings PLC - MarketBeat

Sep 09, 2026
pulisher
Sep 08, 2026

U.S. Earnings Preview: After Market Close Sept. 8 - moomoo.com

Sep 08, 2026
pulisher
Sep 06, 2026

Irenic Capital Management LP Makes New Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 06, 2026
pulisher
Sep 06, 2026

Bank of New York Mellon Corp Makes New $3.81 Million Investment in AnaptysBio, Inc. $ANAB - MarketBeat

Sep 06, 2026
pulisher
Sep 04, 2026

AnaptysBio Inc. (ANAB) Shareholding Pattern – Promoters, FIIs & DIIs - Value Research

Sep 04, 2026
pulisher
Sep 04, 2026

ANAB Q2'26 Earnings: revenue estimate is 8.89M USD - TradingView

Sep 04, 2026
pulisher
Sep 02, 2026

Anaptys Announces Participation at the H.C. Wainwright 28th Annual Global Investment Conference - The Manila Times

Sep 02, 2026
pulisher
Sep 01, 2026

U.S. Earnings Preview: After Market Close Sept. 1 - Moomoo

Sep 01, 2026
pulisher
Aug 31, 2026

AnaptysBio stock rating maintained at Outperform by Wolfe Research - Investing.com Nigeria

Aug 31, 2026
pulisher
Aug 30, 2026

AnaptysBio earnings on deck: Can Jemperli offset revenue slide? By Investing.com - Investing.com Australia

Aug 30, 2026
$96.90
price up icon 0.05%
$57.16
price down icon 0.82%
$35.72
price up icon 0.62%
$219.72
price down icon 4.96%
ONC ONC
$358.07
price down icon 0.20%
$206.64
price up icon 0.36%
Capitalizzazione:     |  Volume (24 ore):